Login
| TI Ref No : | 517690862 |
|---|---|
| Description : | Contract Awarded For L04af03 Decadesitinib; L04ac18 Risanakizumab the Subject Of The Public Contract Is Continuous Supplies Of Drugs Containing The Active Substance L04af03 Fallen; L04ac18 Risankizumab For 4 Years. The Contracting Authority Only Requires |
| Date : | 2025-05-08 |
| Deadline : | 2025-07-16 |
| Document Type : | Contracts |
